Atlas Trials

Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Experiencing a PMR Relapse

Clinical trial NCT05533164 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05533164
Sponsor
Sint Maartenskliniek
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Polymyalgia Rheumatica
Start date
2023-02-09
Primary completion
2027-01-01
Enrollment
174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.